Leading federal aging research and policy since 1974
A review of mobility and balance assessments shows they indicate functional health and fall risk, not life expectancy. Tests like sit-to-stand and Timed Up and Go help identify weaknesses and guide care, while researchers note variability across populations.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.